Drugs / Lu AF87908
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04149860 | Sep 2019 → Jul 2023 | Alzheimer disease | H. Lundbeck A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AF87908 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04149860 ↗ |
| Route | Intravenous | “intravenous (IV) infusion” NCT04149860 ↗ |